When you have areas with a focus that are not too broadly set, such as biosciences and life sciences, but rather get a specific focus like agricultural biotechnology here in Saskatoon, that raises investor confidence. If you have the mechanisms in place to achieve a certain level of technology maturation so that it's investment-ready, you can have successes in these places.
We mentioned one company earlier, Saponin, that is raising capital and is successful at getting investment made in it. Part of the reason it has achieved that state is that the technology has gone from the early-stage research done in a government lab, at the right time turned into a company, and that company is given a location to incubate. All of this comes together to the point that they can now go out to private investors and attract investment. They have the confidence to invest because they're within this community that they know is surrounded by the university, the PBI, the kinds of investments that are available from Genome Prairie. The HQP are going to be here.
Canada has the capacity to win in these areas as long as it does the focus thing. The part we get into trouble with is if we try to do a general spreading of the activity around all the different possibilities. You have to narrow it down. I think we know that Saskatoon is a very successful cluster because it's focused.